These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [The importance of oxytocin and prostaglandins to the mechanism of labor in humans]. Husslein P Wien Klin Wochenschr Suppl; 1984; 155():1-32. PubMed ID: 6099005 [TBL] [Abstract][Full Text] [Related]
28. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor. Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092 [TBL] [Abstract][Full Text] [Related]
29. The effect of continuous morphine administration on maternal plasma oxytocin concentration and uterine contractions after open fetal surgery. Santolaya-Forgas J; Romero R; Mehendale R J Matern Fetal Neonatal Med; 2006 Apr; 19(4):231-8. PubMed ID: 16854697 [TBL] [Abstract][Full Text] [Related]
30. [Stimulation and inhibition of uterine contractions from the modern viewpoint]. Fröhlich H Wien Med Wochenschr; 1986 Jun; 136(11-12):260-3. PubMed ID: 2875565 [TBL] [Abstract][Full Text] [Related]
31. Progress in the development of oxytocin antagonists for use in preterm labor. Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024 [TBL] [Abstract][Full Text] [Related]
32. Contractility of the myometrium; the rationale for pharmacological intervention in preterm labour. Akerlund M; Marsál K Exp Physiol; 2001 Nov; 86(6):825-6. PubMed ID: 11698980 [No Abstract] [Full Text] [Related]
33. Interruption of parturition in rats by morphine: a result of inhibition of oxytocin secretion. Russell JA; Gosden RG; Humphreys EM; Cutting R; Fitzsimons N; Johnston V; Liddle S; Scott S; Stirland JA J Endocrinol; 1989 Jun; 121(3):521-36. PubMed ID: 2754376 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of vasopressin effects on the uterus by a synthetic analogue. Akerlund M; Strömberg P; Forsling ML; Melin P; Vilhardt H Obstet Gynecol; 1983 Sep; 62(3):309-12. PubMed ID: 6877687 [TBL] [Abstract][Full Text] [Related]
35. Oxytocin antagonists and their therapeutic use. Melin P Regul Pept; 1993 Apr; 45(1-2):285-8. PubMed ID: 8390080 [No Abstract] [Full Text] [Related]
36. Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women. Steinwall M; Bossmar T; Gaud C; Akerlund M Acta Obstet Gynecol Scand; 2004 Jan; 83(1):12-8. PubMed ID: 14678081 [TBL] [Abstract][Full Text] [Related]
37. The effect of berotec (Th 1165a) on spontaneous and induced uterine activity in the pregnant baboon. Lauersen NH; Wilson KH; Fuchs F Am J Obstet Gynecol; 1975 Mar; 121(5):597-601. PubMed ID: 234685 [TBL] [Abstract][Full Text] [Related]
38. The behaviour of pelvic floor muscles during uterine contractions in spontaneous and oxytocin-induced labour. Karahan N; Arslan H; Çam Ç J Obstet Gynaecol; 2018 Jul; 38(5):629-634. PubMed ID: 29430972 [TBL] [Abstract][Full Text] [Related]
39. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor. Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330 [TBL] [Abstract][Full Text] [Related]
40. Progress in the development of oxytocin antagonists for use in preterm labor. Williams PD; Bock MG; Evans BE; Freidinger RM; Pettibone DJ Adv Exp Med Biol; 1998; 449():473-9. PubMed ID: 10026841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]